Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regulation of CD1d expression and function by a herpesvirus infection
David Jesse Sanchez, Jenny E. Gumperz, Don Ganem
David Jesse Sanchez, Jenny E. Gumperz, Don Ganem
View: Text | PDF
Article Virology

Regulation of CD1d expression and function by a herpesvirus infection

  • Text
  • PDF
Abstract

Little is known about the role of CD1d-restricted T cells in antiviral immune responses. Here we show that the lytic replication cycle of the Kaposi sarcoma–associated herpesvirus (KSHV) promotes downregulation of cell-surface CD1d. This is caused by expression of the 2 modulator of immune recognition (MIR) proteins of the virus, each of which promotes the loss of surface CD1d expression following transfection into uninfected cells. Inhibition of CD1d surface expression is due to ubiquitination of the CD1d α-chain on a unique lysine residue in its cytoplasmic tail, which triggers endocytosis. Unlike MIR-mediated MHC class I downregulation, however, CD1d downregulation does not appear to include accelerated lysosomal degradation. MIR2-induced downregulation of CD1d results in reduced activation of CD1d-restricted T cells in vitro. KSHV modulation of CD1d expression represents a strategy for viral evasion of innate host immune responses and implicates CD1d-restricted T cells as regulators of this viral infection.

Authors

David Jesse Sanchez, Jenny E. Gumperz, Don Ganem

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
MIR2 downregulation of CD1d lowers CD1d-restricted T cell activation. (A...
MIR2 downregulation of CD1d lowers CD1d-restricted T cell activation. (A) BJAB cells stably transduced with either lacZ (gray bars) as a control or MIR2 (white bars) were cocultured with CD1d-restricted T cells. This coculture was done in the presence of α-GalCer to provide an activating ligand for the T cells. Each coculture was performed in triplicate. After 18 hours of coculture, each supernatant was assayed for IFN-γ release by ELISA. (B) As in A, coculture experiments were done with CD1d-restricted T cells and BJAB cells, this time either in the presence or absence of α-GalCer. Cocultures were done with α-GalCer lacZ (light gray bars), α-GalCer MIR2 (white bars), lacZ without α-GalCer (black bars), and MIR2 without α-GalCer (dark gray bars). After 18 hours, the supernatants were recovered, and the IFN-γ in each supernatant was assayed by ELISA. (C) As in A, coculture experiments were done with CD1d-restricted T cells and BJAB cells, either in the presence of mouse anti–MHC class I as a control (lacZ, dark gray bars; MIR2, white bars) or mouse anti-CD1d (lacZ, black bars; MIR2, light gray bars). After 18 hours, the supernatants were recovered, and the IFN-γ in each supernatant was assayed by ELISA. Results are shown as means ± SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts